Adverse maternal and neonatal outcomes among women with preeclampsia with severe features <34 weeks gestation with versus without comorbidity

類似資料

• Severe Preeclampsia versus HELLP Syndrome: Maternal and Perinatal Outcomes at <34 and ≥34 Weeks’ Gestation
  著者:: Kınay, Tuğba, 等
  出版事項: (2015)
• Severe Preeclampsia versus HELLP Syndrome: Maternal and Perinatal Outcomes at <34 and ≥34 Weeks’ Gestation
  著者:: Tuğba Kınay, 等
  出版事項: (2015-12-01)
• Comparing neonatal respiratory morbidity in neonates delivered after 34 weeks of gestation with and without antenatal corticosteroid
  著者:: Karakaya, Burcu Kisa, 等
  出版事項: (2017)
• COVID-19 and preeclampsia with severe features at 34-weeks gestation
  著者:: Hansen, John N., 等
  出版事項: (2021)
• Low-dose aspirin at ≤16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis
  著者:: Cui, Yuechong, 等
  出版事項: (2018)